Infinium Pharma

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MRE01011
  • NSEID: INFINIUM
  • BSEID:
INR
221.10
-3.8 (-1.69%)
BSENSE

Dec 19

BSE+NSE Vol: 1000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
Operating Income
155.00
135.00
114.00
99.00
70.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
Net Sales
155.00
135.00
114.00
99.00
70.00
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
-4.00
0.00
-1.00
-3.00
Raw Materials Consumed
123.00
108.00
80.00
78.00
57.00
Power & Fuel Cost
1.00
1.00
0.00
0.00
0.00
Employee Cost
7.00
5.00
5.00
3.00
2.00
Operating Expenses
0.00
1.00
1.00
0.00
0.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
2.00
1.00
0.00
1.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
3.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
Total Expenditure
139.00
117.00
98.00
89.00
65.00
Operating Profit (PBDIT) excl Other Income
16.00
18.00
16.00
10.00
4.00
Other Income
2.00
1.00
1.00
0.00
0.00
Operating Profit (PBDIT)
18.00
20.00
17.00
10.00
5.00
Interest
3.00
2.00
3.00
1.00
1.00
Profit before Depriciation and Tax
14.00
17.00
14.00
9.00
4.00
Depreciation
3.00
2.00
1.00
0.00
0.00
Profit Before Taxation & Exceptional Items
11.00
15.00
12.00
8.00
3.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
11.00
15.00
12.00
8.00
3.00
Provision for Tax
3.00
3.00
3.00
1.00
1.00
Profit After Tax
7.00
11.00
9.00
6.00
2.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
28.00
17.00
11.00
5.00
2.00
Profit Available for appropriations
36.00
28.00
20.00
11.00
5.00
Appropriations
36.00
28.00
20.00
11.00
5.00
Equity Dividend (%)
0.00%
0.00%
0.00%
0.00%
0.00%
Earnings Per Share
5.60
10.61
6.82
60.07
26.80
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 14.78% vs 18.76% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -11.21% vs 15.26% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 70.22% vs -30.52% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -31.82% vs 17.17% in Mar 2024

Compare Profit and Loss Results of Infinium Pharma
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
155.00
367.00
-212.00
-57.77%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
155.00
367.00
-212.00
-57.77%
Expenditure (Ex Depriciation)
Stock Adjustments
-6.00
-14.00
8.00
57.14%
Raw Materials Consumed
123.00
185.00
-62.00
-33.51%
Power & Fuel Cost
1.00
13.00
-12.00
-92.31%
Employee Cost
7.00
53.00
-46.00
-86.79%
Operating Expenses
0.00
31.00
-31.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
24.00
-22.00
-91.67%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
3.00
6.00
-3.00
-50.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
139.00
326.00
-187.00
-57.36%
Operating Profit (PBDIT) excl Other Income
16.00
41.00
-25.00
-60.98%
Other Income
2.00
5.00
-3.00
-60.00%
Operating Profit (PBDIT)
18.00
46.00
-28.00
-60.87%
Interest
3.00
6.00
-3.00
-50.00%
Profit before Depriciation and Tax
14.00
39.00
-25.00
-64.10%
Depreciation
3.00
15.00
-12.00
-80.00%
Profit Before Taxation & Exceptional Items
11.00
23.00
-12.00
-52.17%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
11.00
23.00
-12.00
-52.17%
Provision for Tax
3.00
6.00
-3.00
-50.00%
Profit After Tax
7.00
17.00
-10.00
-58.82%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
28.00
140.00
-112.00
-80.00%
Profit Available for appropriations
36.00
157.00
-121.00
-77.07%
Appropriations
36.00
157.00
-121.00
-77.07%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.6
3.54
2.06
58.19%
Profit And Loss - Net Sales
Net Sales 155.71 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 14.78% vs 18.76% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 16.42 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -11.21% vs 15.26% in Mar 2024

Profit And Loss - Interest
Interest 3.67 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 70.22% vs -30.52% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 7.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -31.82% vs 17.17% in Mar 2024